Agile Therapeutics to Present at The H.C. Wainwright Global Investment Conference
Agile Therapeutics (Nasdaq: AGRX) announced that CEO Al Altomari will present at the H.C.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Agile Therapeutics (Nasdaq: AGRX) announced that CEO Al Altomari will present at the H.C. Wainwright Global Investment Conference on May 24, 2022, from 10:00-10:30 am ET. The conference will take place in Miami, FL, from May 23-26, 2022. The presentation will be available via live webcast on the company’s investor relations page, with a replay archived for 90 days. Agile Therapeutics focuses on women's healthcare, providing innovative contraceptive options through its proprietary Skinfusion technology.
Details
News Market Reaction – AGRX
The recorded move for AGRX in the trading session of this news was -7.14%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PRINCETON, N.J., May 17, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, announced that Al Altomari, Chairman and Chief Executive Officer, will present at the H.C. Wainwright Global Investment Conference taking place May 23-May 26, 2022 in Miami, FL. Details on the Company presentation are as follows:
| Event: | H.C. Wainwright Global Investment Conference |
| Date: | Tuesday, May 24, 2022 |
| Time: | 10:00-10:30 am ET |
The H.C. Wainwright Global Investment Conference webcast will be available on the investor relations page of the Company’s website at https://ir.agiletherapeutics.com/events-and-presentations. The replay of the webcast will be archived on the website for approximately 90 days.
About Agile Therapeutics, Inc.
Agile Therapeutics is a forward-thinking women's healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla and our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. Twirla® and our pipeline products are based on our proprietary transdermal patch technology, called Skinfusion®, which is designed to allow drug delivery through the skin. For more information, please visit the company website at www.agiletherapeutics.com. The Company may occasionally disseminate material, nonpublic information on the Company’s website.
Contact:
Matt Riley
Head of Investor Relations
mriley@agiletherapeutics.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.